Search research articles
Contact Us
Filters
Showing results (1141-1150 of 39,482) with videos related to
Page
of 3,949
Sort By:
Blood
|
February 7, 2020
Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study
Francisco Pedrosa, Elaine Coustan-Smith, Yinmei Zhou, et al.
Blood
|
February 11, 2020
Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs
Marco De Dominici, Patrizia Porazzi, Youcai Xiao, et al.
Blood
|
January 10, 2020
Novel antithrombotic strategies for treatment of venous thromboembolism
Jeffrey I Weitz, Noel C Chan
Blood
|
January 15, 2020
High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity
Tom Erkers, Bryan J Xie, Laura J Kenyon, et al.
Blood
|
January 16, 2020
Fyn Kinase Is Involved in EPO Receptor Signaling and Is Required to Harmonize the Response to Oxidation
Elisabetta Beneduce, Alessandro Mattè, Luigia De Falco, et al.
Blood
|
January 17, 2020
Virus-specific T-cell therapies for patients with primary immune deficiency
Michael D Keller, Catherine M Bollard
Blood
|
January 17, 2020
Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection
Stuart G Tangye, Sylvain Latour
Blood
|
January 17, 2020
Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency
Ottavia M Delmonte, Anna Villa, Luigi D Notarangelo
Blood
|
January 17, 2020
Wdr26 regulates nuclear condensation in developing erythroblasts
Ru Zhen, Chingyee Moo, Zhenzhen Zhao, et al.
Blood
|
January 18, 2020
How I assess and manage the risk of bleeding in patients treated for venous thromboembolism
Frederikus A Klok, Menno V Huisman
Page
of 3,949
Search research articles
Search
Showing results (1141-1150 of 39,482) with videos related to
Sort By:
Page
of 3,949
Blood
|
February 7, 2020
Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study
Francisco Pedrosa, Elaine Coustan-Smith, Yinmei Zhou, et al.
Blood
|
February 11, 2020
Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs
Marco De Dominici, Patrizia Porazzi, Youcai Xiao, et al.
Blood
|
January 10, 2020
Novel antithrombotic strategies for treatment of venous thromboembolism
Jeffrey I Weitz, Noel C Chan
Blood
|
January 15, 2020
High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity
Tom Erkers, Bryan J Xie, Laura J Kenyon, et al.
Blood
|
January 16, 2020
Fyn Kinase Is Involved in EPO Receptor Signaling and Is Required to Harmonize the Response to Oxidation
Elisabetta Beneduce, Alessandro Mattè, Luigia De Falco, et al.
Blood
|
January 17, 2020
Virus-specific T-cell therapies for patients with primary immune deficiency
Michael D Keller, Catherine M Bollard
Blood
|
January 17, 2020
Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection
Stuart G Tangye, Sylvain Latour
Blood
|
January 17, 2020
Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency
Ottavia M Delmonte, Anna Villa, Luigi D Notarangelo
Blood
|
January 17, 2020
Wdr26 regulates nuclear condensation in developing erythroblasts
Ru Zhen, Chingyee Moo, Zhenzhen Zhao, et al.
Blood
|
January 18, 2020
How I assess and manage the risk of bleeding in patients treated for venous thromboembolism
Frederikus A Klok, Menno V Huisman
Page
of 3,949